N-terminal polyubiquitination and degradation of the Arf tumor suppressor
about
Explaining oscillations and variability in the p53-Mdm2 systemTranscription-independent ARF regulation in oncogenic stress-mediated p53 responsesThe autophagic inducer smARF interacts with and is stabilized by the mitochondrial p32 proteinNucleophosmin serves as a rate-limiting nuclear export chaperone for the Mammalian ribosomePoly(A) binding protein (PABP) homeostasis is mediated by the stability of its inhibitor, Paip2Tumor suppressor ARF promotes non-classic proteasome-independent polyubiquitination of COMMD1Ribosomal protein S9 is a novel B23/NPM-binding protein required for normal cell proliferationA novel ARF-binding protein (LZAP) alters ARF regulation of HDM2The ubiquitin-conjugating enzyme (E2) Ube2w ubiquitinates the N terminus of substratesMolecules that target nucleophosmin for cancer treatment: an updateStructural polymorphism in the N-terminal oligomerization domain of NPM1Insights into the regulation of neuronal viability by nucleophosmin/B23Divorcing ARF and p53: an unsettled caseDirect promoter induction of p19Arf by Pit-1 explains the dependence receptor RET/Pit-1/p53-induced apoptosis in the pituitary somatotroph cellsNucleophosmin and its AML-associated mutant regulate c-Myc turnover through Fbw7 gammaNucleophosmin is required for DNA integrity and p19Arf protein stabilityGLTSCR2 promotes the nucleoplasmic translocation and subsequent degradation of nucleolar ARFProtein post-translational modifications: In silico prediction tools and molecular modeling.Sumoylation induced by the Arf tumor suppressor: a p53-independent functionSmall mitochondrial Arf (smArf) protein corrects p53-independent developmental defects of Arf tumor suppressor-deficient mice.Towards a functional understanding of protein N-terminal acetylationDynamics of ARF regulation that control senescence and cancer.Regulating SWI/SNF subunit levels via protein-protein interactions and proteasomal degradation: BAF155 and BAF170 limit expression of BAF57Ubiquitin proteasome-dependent degradation of the transcriptional coactivator PGC-1{alpha} via the N-terminal pathwayRegulation of p14ARF expression by miR-24: a potential mechanism compromising the p53 response during retinoblastoma development.N-terminal hemagglutinin tag renders lysine-deficient APOBEC3G resistant to HIV-1 Vif-induced degradation by reduced polyubiquitination.AKT regulates NPM dependent ARF localization and p53mut stability in tumors.Complex regulation controls Neurogenin3 proteolysis.Ubiquitin and ubiquitin-like proteins in the nucleolus: multitasking tools for a ribosome factory.CDK5RAP3 is a novel repressor of p14ARF in hepatocellular carcinoma cells.Nucleostemin stabilizes ARF by inhibiting the ubiquitin ligase ULF.New insights into BS69 functions.Mimicking p14ARF phosphorylation influences its ability to restrain cell proliferation.Impact of the N-terminal amino acid on targeted protein degradation.Potential roles for ubiquitin and the proteasome during ribosome biogenesis.Nucleophosmin (NPM1) mutations in adult and childhood acute myeloid leukaemia: towards definition of a new leukaemia entity.The N-terminal domain of MyoD is necessary and sufficient for its nuclear localization-dependent degradation by the ubiquitin systemLysine-independent turnover of cyclin G1 can be stabilized by B'alpha subunits of protein phosphatase 2A.Ubiquitylation on canonical and non-canonical sites targets the transcription factor neurogenin for ubiquitin-mediated proteolysisIntracellular CD24 disrupts the ARF-NPM interaction and enables mutational and viral oncogene-mediated p53 inactivation
P2860
Q21202791-D5081D57-3D43-42A5-9038-AF049BD4591BQ24301836-23CB53E7-CEBC-4791-A75C-EB76DCBEEF9EQ24305067-F6B6671B-D8B6-424F-BA7D-0E27B77A5068Q24315004-60D9D32E-5EED-45AC-90F0-4275840DC4A9Q24315558-B4021024-3A86-4625-AD96-72ADAD8E28D8Q24318304-CAD6A243-3AA8-4F08-BA3A-C36E02FF2E9CQ24322997-CD15ED6D-88F6-43D6-8297-B85A9D6A7D4FQ24328749-AAF4B447-AD8F-477A-93AF-2F384C75F2B5Q24605908-EA4ACC04-D9E5-4A99-82DF-05169B069E6AQ26750653-C7E4ABDD-35E7-470C-8740-B79D1723C394Q27682111-1CBACB01-B323-4E41-8F19-105DA7BF1D4FQ28082431-BAEF518C-F399-4701-A8AB-B0A9675D1B9FQ28258356-6D6DEC9A-9BA7-410A-9230-1E2CA27B2926Q28576734-09CE0B72-017A-4E2E-9FFF-977B03B1E2CFQ28589317-B482EEE9-BAF7-438E-9932-486DE25CF242Q28593126-4ED7F194-095D-44E8-88A7-5554B4FD97BCQ30032677-69A302F6-0508-4B14-B375-030634BEBEEEQ33580119-88A365CE-F417-4206-846E-D99228446749Q33821331-3D46CF5D-52EC-437E-8D10-7805904069A3Q33913688-1ECE597C-3B6C-48D0-A26B-2E9763E78409Q33927359-3177FC63-12EB-4862-AABC-CD1144ACB979Q34047232-3317E29F-7A54-436A-90F1-6C8B0FECBFAFQ34097266-0835A5B1-FC94-47DA-909B-D33050DBA223Q34131460-3079EB69-A4F3-4F70-8AAD-E869AAB09A8EQ34159585-CABC32F7-46CC-4F6D-9E64-47ECBEB52600Q34166447-26D61E9C-EE6D-4661-B8FA-5F26D4682EF5Q34227622-4C855C9D-3682-45EA-B89F-417AF1E2D569Q34319004-653BE698-F7D3-40BC-8EB1-FC757C0EF0C6Q34347040-FFAFB446-35B9-41E1-A0DC-EA5121B7E32DQ34364651-2E6F07AA-945F-4985-906C-47DD1D978EE9Q34417328-874131EE-17F0-428D-848A-55B4E2CFAC6BQ34505578-CA5F1AD0-8E10-489D-B528-0DA51AD43C1BQ34545274-35403A99-E0FA-4EA5-A70E-D4568C0EFC9EQ34557941-8E90F307-AB03-48B5-AA20-7E901CB6572EQ34718323-B3625644-A70E-4301-BA8E-65C491C57C9BQ34755985-4941EEF8-34CC-44EC-981C-B401F62F6733Q34845706-C0142EBF-949B-401A-B160-D7C10C50E46FQ34871504-0019D907-0197-41A2-92A3-36727FEA0855Q34972149-DC443F91-6231-4C57-89B8-34F31CE8E5D8Q34990640-50662886-7720-436C-AE79-AED4D2CC3E61
P2860
N-terminal polyubiquitination and degradation of the Arf tumor suppressor
description
2004 nî lūn-bûn
@nan
2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
N-terminal polyubiquitination and degradation of the Arf tumor suppressor
@ast
N-terminal polyubiquitination and degradation of the Arf tumor suppressor
@en
N-terminal polyubiquitination and degradation of the Arf tumor suppressor
@nl
type
label
N-terminal polyubiquitination and degradation of the Arf tumor suppressor
@ast
N-terminal polyubiquitination and degradation of the Arf tumor suppressor
@en
N-terminal polyubiquitination and degradation of the Arf tumor suppressor
@nl
prefLabel
N-terminal polyubiquitination and degradation of the Arf tumor suppressor
@ast
N-terminal polyubiquitination and degradation of the Arf tumor suppressor
@en
N-terminal polyubiquitination and degradation of the Arf tumor suppressor
@nl
P2093
P2860
P3181
P356
P1433
P1476
N-terminal polyubiquitination and degradation of the Arf tumor suppressor
@en
P2093
Charles J Sherr
David Bertwistle
Mei-Ling Kuo
Willem den Besten
P2860
P304
P3181
P356
10.1101/GAD.1213904
P407
P577
2004-08-01T00:00:00Z